Production

The production plant is built on an area of 26,000sqm. It has got 15,000sqm of roofed surface divided into production areas of 6,000sqm, research and develomplent areas of 3,000sqm, storage facilities of 5,000sqm, commercial offices of 1,000sqm and a remaining area of 6,000sqm available for further expansion.
Thanks to the constant investments in quality and technology, the company has considerably enlarged its portfolio of produced drugs also on behalf of important corporations, thus becoming the ideal partner for production and development of new pharmaceutical dossiers.

The company's philosophy has always been growing of its activities through the enforcement of standards of quality adequate to the most recent and strict international rules.
The characteristics of production are those of high standards of quality and for the technological support provided to the customer companies.

The company has always been capable to manage the several requests from the pharmaceutical industries, offering a great deal of services relating to the different phases of developing, manufactoring and quality control for pharmaceutical products according to the Good Manufacturing Practice (GMP) and to the leading pharmacopoeias such as EP, BP, USP, JP etc.

The company is specialised in the production of drugs:

Beta-lattamic antibiotics

injectable sterile powder, tablets, capsule, oral suspensions

injectable sterile solutions

asepsis or sterilisable vials

oral solids

tablets, hard capsules, dry/wet granulates

oral liquids

syrups, suspensions, disposable bottle also equipped with measured cork

Semi-solids

gels, creams

The company also offers its partners the following services:

• development of new formulations;
• development and validation of analytic and microbiological methods;
• stability studies in accordance with the ICH;
• editing of dossiers and technical documentation in CTD format;
• process validations.

Particles contaminated production area

Sensitising beta-lattamic drugs are produced in this area. It is strictly segregated as a building and as well as for services to avoid risks of cross contamination from and to other production areas.
Units which are built according to the highest standards are kept separated and equipped with their own independent treatment machinery.

Sterile powder ripartition machineries are characterised by a great deal of flexibility and capacity:
vials from 20 to 100 ml with dosage from 0.25 g to 20g for a single vial;
capacity of 2,000 vials per hour for a 100ml vial to 8,000 vials per hour for a 20 ml vial. 

Quality system

The company's quality system is made of 12 KEY SOPs which generate all the SOPs and GMP activities that allow the Company to operate in accordance with the greatest quality criteria